Drug Shortage Report for BREVIBLOC PREMIXED INJECTION
Report ID | 17549 |
Drug Identification Number | 02309238 |
Brand name | BREVIBLOC PREMIXED INJECTION |
Common or Proper name | Brevibloc Premixed Injection |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ESMOLOL HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250mL Intravia Container |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-07-27 |
Actual start date | 2017-07-27 |
Estimated end date | 2017-08-08 |
Actual end date | 2017-08-08 |
Shortage status | Resolved |
Updated date | 2017-08-09 |
Company comments | Product can be subistituted with Brevibloc vials, reconstiued in saline IV infusion bag as per the applicable dosage. Drug concentration: 10 mg/ mL (100 mg/10 mL Vials). - Product code : CA2L9119 - DIN 02188880 - Pack size:10 mL - Units/ CA: 100 units - Storage: Store vials at 15˚C to 25˚C |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-08-09 | English | Compare |
v6 | 2017-08-08 | French | Compare |
v5 | 2017-08-08 | English | Compare |
v4 | 2017-08-03 | French | Compare |
v3 | 2017-08-03 | English | Compare |
v2 | 2017-07-31 | French | Compare |
v1 | 2017-07-31 | English | Compare |
Showing 1 to 7 of 7